Advanced imaging system for studying diseases in animals
State-of-the-Art Preclinical PET/CT Imaging System
This study is working to upgrade the imaging technology at the Yale PET Center so that researchers can better see how diseases like cancer and heart conditions affect different animals, which will help improve treatments for both pets and people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10853946 on NIH RePORTER |
What this research studies
This research aims to replace an outdated Positron Emission Tomography (PET) imaging system with a new PET/CT system at the Yale PET Center. This advanced imaging technology will allow researchers to non-invasively observe and measure biochemical processes and physiological functions in various animal species, including mice, rats, birds, rabbits, dogs, and nonhuman primates. By enhancing the capabilities of preclinical imaging, this project will support the development of new radiopharmaceuticals and improve our understanding of diseases such as cancer, heart conditions, and metabolic disorders. The research will ultimately contribute to better diagnostic and therapeutic strategies in veterinary and human medicine.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include animals with conditions related to oncology, cardiology, and metabolic disorders.
Not a fit: Patients who are not animals or do not have conditions relevant to the imaging capabilities of the PET/CT system may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for various diseases in both animals and humans.
How similar studies have performed: Other research has successfully utilized advanced imaging technologies in preclinical studies, indicating a strong potential for this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Normandin, Marc David — Yale University
- Study coordinator: Normandin, Marc David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.